COVID-19advanced/metastatic canceradvanced/metastatic solid tumorshepatocellular carcinomatype 2 diabetes mellitusECOG Performance StatusNP-101
….0002). A double-blind, randomized, placebo-controlled trial in COVID-19 patients14 demonstrated that NP-101 led to a faster decline in …